MeVis Medical Solutions AG (XTER:M3V) Debt-to-Equity : 0.00 (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is MeVis Medical Solutions AG Debt-to-Equity?

MeVis Medical Solutions AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.00 Mil. MeVis Medical Solutions AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.00 Mil. MeVis Medical Solutions AG's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €17.83 Mil. MeVis Medical Solutions AG's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for MeVis Medical Solutions AG's Debt-to-Equity or its related term are showing as below:

During the past 13 years, the highest Debt-to-Equity Ratio of MeVis Medical Solutions AG was 0.29. The lowest was 0.01. And the median was 0.13.

XTER:M3V's Debt-to-Equity is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 0.48
* Ranked among companies with meaningful Debt-to-Equity only.

MeVis Medical Solutions AG Debt-to-Equity Historical Data

The historical data trend for MeVis Medical Solutions AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeVis Medical Solutions AG Debt-to-Equity Chart

MeVis Medical Solutions AG Annual Data

Trend

Dec13

Dec14

Dec15

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Debt-to-Equity

Get a 7-Day Free Trial

MeVis Medical Solutions AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of MeVis Medical Solutions AG's Debt-to-Equity

For the Health Information Services subindustry, MeVis Medical Solutions AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MeVis Medical Solutions AG's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where MeVis Medical Solutions AG's Debt-to-Equity falls into.

MeVis Medical Solutions AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

MeVis Medical Solutions AG's Debt to Equity Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	17.826
	=	0.00

MeVis Medical Solutions AG's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	17.826
	=	0.00

MeVis Medical Solutions AG (XTER:M3V) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

MeVis Medical Solutions AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of MeVis Medical Solutions AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

MeVis Medical Solutions AG (XTER:M3V) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MeVis Medical Solutions AG (XTER:M3V) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

M3V:Germany M3V:Germany

Address

Caroline-Herschel-Strasse 1, Bremen, DEU, 28359

Website

http://www.mevis.de

MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.

MeVis Medical Solutions AG (XTER:M3V) Headlines

No Headlines